Medication Reconciliation in Home Health: More Than Updating a Medication List
Medication reconciliation in home health is often treated as a task of comparing medication lists and correcting discrepancies. But an accurate list is only the starting point.
A patient’s medication information may come from several places: a hospital discharge summary, physician orders, the agency’s medication profile, pharmacy records, and the medication bottles or pill organisers found in the home. These sources may not always agree.
Sometimes the difference reflects a legitimate change in treatment. At other times, it may indicate outdated information, a misunderstanding, an uncommunicated prescription change, or a patient who is not taking medication as intended.
The important question is not simply whether the lists match. It is whether the clinician can establish what the patient is currently taking, identify potential concerns, and ensure that discrepancies requiring action are followed up appropriately.
Why Medication Reconciliation Matters in Home Health
Medication reconciliation is closely connected to patient safety, continuity of care and clinical documentation. It involves comparing available medication information with what the patient is actually taking, identifying discrepancies and determining what needs clarification or follow-up.
CMS’s Home Health Quality Reporting Program (HH QRP) includes a related measure called Drug Regimen Review Conducted with Follow-Up for Identified Issues. The measure evaluates whether a drug regimen review was conducted at start of care (SOC) or resumption of care (ROC), and whether recommended actions following timely physician follow-up were completed when potential or actual clinically significant medication issues were identified.
Drug regimen review and medication reconciliation are closely related, but the terms should not be treated as interchangeable. The quality measure specifically addresses drug regimen review and follow-up, while the broader clinical process of medication reconciliation focuses on identifying and resolving differences in medication information.
Under 42 CFR § 484.55(c)(5), the home health comprehensive assessment must include a review of all medications the patient is currently using to identify potential adverse effects and drug reactions. This includes ineffective therapy, significant side effects, significant drug interactions, duplicate drug therapy and noncompliance with drug therapy.
Together, these requirements highlight an important distinction: reviewing medication information is not the same as resolving a medication-related concern.
Official references:
The Clinical Questions Behind the Medication List
When medication information differs across sources, the clinician needs to understand the context rather than automatically choosing one version.
Key questions include:
Is there a discrepancy between the available records and what the patient is taking?
Could the difference reflect an intentional change in treatment?
What does the patient or caregiver report about current medication use?
Is there a potential safety, effectiveness, interaction or adherence concern?
Does the issue require education, clarification, communication with the prescriber or further monitoring?
These questions help distinguish a documentation inconsistency from a concern that may require clinical follow-up.
When Two Medication Lists Do Not Match
Consider a patient whose hospital discharge summary lists lisinopril 20 mg daily, while the agency medication profile and the bottle in the home show 10 mg daily.
The patient reports that a cardiologist recently reduced the dose, but the available records do not confirm the change.
Simply updating the agency profile to match one source would not resolve the discrepancy. Nor should the clinician independently assume which dose is correct.
The discrepancy needs to be documented, the available information reviewed, and the appropriate prescriber contacted for clarification when indicated. Any change to the medication record should follow verification and the applicable clinical and agency process.
A more useful note would capture the difference, the source of the information, the patient’s report, the clarification or follow-up undertaken, and the outcome.
For example:
Hospital discharge documentation lists lisinopril 20 mg daily. The medication bottle and agency profile reflect 10 mg daily. The patient reports a dose reduction at a recent cardiology visit; however, the available records do not confirm the change. Prescriber contacted for clarification. Medication profile to be updated following verification.
This records more than a mismatch. It makes the clinical follow-up visible.
The Medication List May Be Correct. The Situation May Not Be.
Medication reconciliation also involves understanding how medications are actually being used.
During a home visit, a clinician may discover that a patient:
Continues taking a medication that was reportedly discontinued.
Is unsure which medication to take or when to take it.
Has difficulty managing several prescriptions.
Reports possible side effects or difficulty following the regimen.
Relies on a caregiver who may need additional guidance.
These details may not be obvious from the medication profile alone. They matter because a record can appear complete while important questions about medication use remain unanswered.
The home setting offers an opportunity to understand these practical challenges and determine whether education, clarification, communication or monitoring is needed.
What Better Documentation Should Capture
Good medication documentation should make the reasoning and follow-up traceable. Depending on the situation, this may include:
The discrepancy: What information differed, and where did it come from?
The patient’s account: What did the patient or caregiver report?
The clinical concern: Was a potential issue identified that required further attention?
The action taken: Was education provided, a prescriber contacted, or additional monitoring arranged?
The outcome: What was clarified, recommended or completed, and what remains outstanding?
Documentation should reflect what was actually assessed, reported, verified and done. It should not imply that a discrepancy has been resolved when clarification is still pending.
Where Technology Can Help—and Where It Must Stop
Medication information can be scattered across referral documents, discharge summaries, existing records and clinician observations. Technology can help bring that information together, organise it, and make differences easier to identify.
AI-supported documentation may also help clinicians structure relevant details and capture follow-up more consistently. But it should not silently decide which medication or dose is correct, turn a patient’s report into a verified prescription change, or replace clinical judgment.
The distinction matters: technology can help surface information and support the documentation process, while the clinician remains responsible for interpreting the situation, taking appropriate action and authenticating the record.
At CoLab NotePro, we believe AI should help clinicians work with important information more clearly—not obscure where that information came from or what still needs to be confirmed.
The Goal Is More Than an Updated List
Medication reconciliation is not complete simply because the medication profile looks tidy. Its value lies in identifying discrepancies, understanding the patient’s actual medication use, recognising potential concerns and documenting appropriate follow-up.
In home health, that process supports continuity across care settings and helps make the clinical record a more accurate account of the patient’s current situation.
A medication list shows what is recorded. Medication reconciliation captures the clinical work needed to understand it.
Comments